Camurus AB

In News

Camurus: Why It Has Become A Meaningful Position In Our Portfolio (CAMRF) - Seeking Alpha

Seeking Alpha - Jan 09, 2026

Declining Stock and Solid Fundamentals: Is The Market Wrong About Camurus AB (publ) (STO:CAMX)? - simplywall.st

simplywall.st - Jan 08, 2026

Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly - Yahoo! Finance Canada

Yahoo! Finance Canada - Jan 09, 2026

Once-a-month shot for a rare hormone disorder heads into key FDA review - Stock Titan

Stock Titan - Jan 09, 2026

Camurus’ acromegaly drug Oclaiz gains FDA review date after resubmitted US filing - TipRanks

TipRanks - Jan 09, 2026

Camurus announces FDA acceptance of NDA resubmission for Oclaiz - MarketScreener

MarketScreener - Jan 09, 2026

Why Camurus AB (publ) (7CA) stock is upgraded to buy - Earnings Growth Summary & AI Driven Stock Reports - ulpravda.ru

ulpravda.ru - Jan 10, 2026

Swedish Biotech Camurus in Talks to Buy US-Based Braeburn in $1 Billion Opioid Market Bet - EU Reporter

EU Reporter - Sep 12, 2025

Earnings call transcript: Camurus Q3 2025 sees revenue growth but stock dips - Investing.com

Investing.com - Nov 06, 2025

Big Pharma Deal: Swedish Camurus to Acquire US Braeburn? - Modern Diplomacy

Modern Diplomacy - Sep 12, 2025

Once-monthly octreotide for acromegaly safe, effective, improves patient-reported outcomes - Healio

Healio - Jul 14, 2025

Camurus announces FDA acceptance of NDA resubmission for Oclaiz - TipRanks

TipRanks - Jan 09, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment